$KITE Form 8-K


Form 8-K for KITE PHARMA, INC.


Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.On June 22, 2015, Kite Pharma, Inc. (“Kite”) and bluebird bio, Inc. (“bluebird”) issued a joint press release announcing that they have entered into a collaboration agreement to advance second generation T cell receptor therapy product candidates to treat certain cancers associated with the human papillomavirus. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.


Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is filed as part of this Current Report:

99.1 Press Release of Kite and bluebird issued June 22, 2015.


Please enter your comment!
Please enter your name here